Veerhealth Care has announced securing new export orders for oral care products from a US client after receiving USFDA clearance. The company has already dispatched three FCL shipments and expects to send 4-5 shipments monthly, significantly boosting revenue and market presence. This development has led to full capacity utilization, improving cost efficiency. Veerhealth Care is also in discussions for exports to the Russian market and is preparing for formalities related to the medical device category in the US. The company projects total revenues of ₹35-40 crore with 10% PAT for FY2025-26 and aims for ₹100 crore revenue with 10% PAT in the next 24-36 months.